OptiBiotix announced that it had signed three commercialisation deals for its weight loss ingredient SlimBiome, one of its two marketed functional food ingredients. These take the total number of commercial deals for SlimBiome to 20 and are an important step towards further expanding the product's geographical reach and hence sales. We expect revenues from SlimBiome to reach nearly £1m in FY2020E, which we believe is conservative, and >£11m by 2024E, driven by growing sales of
06 Dec 2019
Three more deals for SlimBiome
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Three more deals for SlimBiome
OptiBiotix Health PLC (OPTI:LON) | 20.2 0 0.0% | Mkt Cap: 19.8m
- Published:
06 Dec 2019 -
Author:
Brigitte de Lima, PHD CFA -
Pages:
5
OptiBiotix announced that it had signed three commercialisation deals for its weight loss ingredient SlimBiome, one of its two marketed functional food ingredients. These take the total number of commercial deals for SlimBiome to 20 and are an important step towards further expanding the product's geographical reach and hence sales. We expect revenues from SlimBiome to reach nearly £1m in FY2020E, which we believe is conservative, and >£11m by 2024E, driven by growing sales of